In a 49-year-old woman with a bulging L4-L5 or L5-S1 disc and severe back spasms, is there a difference in pain relief between oral prednisone and a Medrol Dose Pack (methylprednisolone)?

No Clinically Meaningful Difference Between Prednisone and Methylprednisolone for Acute Lumbar Radiculopathy

There is no clinically significant difference between oral prednisone and a Medrol Dose Pack (methylprednisolone) for treating acute lumbar radiculopathy with disc herniation—both are equally ineffective at reducing pain and provide only modest functional improvement at best.

Evidence-Based Recommendation

The 2017 American College of Physicians systematic review found that systemic corticosteroids (regardless of specific agent) consistently showed no differences versus placebo in pain relief for radicular low back pain 1. Six trials evaluating various systemic corticosteroids—including both prednisone and methylprednisolone—found no pain reduction benefits 1.

Key Clinical Findings

Pain Relief:

• Neither prednisone nor methylprednisolone provides meaningful pain reduction for radiculopathy
• The largest high-quality trial (n=269) using oral prednisone 60 mg/day showed no improvement in leg pain at any time point 2
• A 2022 Cochrane review confirmed systemic corticosteroids may slightly decrease pain by only 0.56 points on a 0-10 scale—clinically insignificant 3

Functional Outcomes:

• Prednisone showed modest functional improvement: 6.4-point improvement on the Oswestry Disability Index at 3 weeks and 7.4 points at 52 weeks 2
• This represents the only measurable benefit, but it's small and doesn't correlate with pain relief
• No difference in surgery rates between steroid-treated and placebo groups 1, 2

Pharmacologic Equivalence

Methylprednisolone and prednisone are pharmacologically similar 4:

• Methylprednisolone has 1.5x the anti-inflammatory potency of prednisolone on average
• Both have comparable duration of action when given orally
• The Medrol Dose Pack delivers approximately 120 mg total methylprednisolone over 6 days
• Standard prednisone tapers deliver 600 mg over 15 days 2

The clinical outcomes are equivalent because both agents fail to provide meaningful benefit for this indication.

Harm Profile

Prednisone causes significantly more adverse events:

• 49% versus 24% for placebo (P<0.001) 1
• Specific harms: insomnia (26% vs 10%), nervousness (18% vs 8%), increased appetite (22% vs 10%) 1
• Short courses appear safe regarding serious adverse events, but common side effects are bothersome 3, 2

Clinical Bottom Line

Do not prescribe either agent for this indication. Your 49-year-old patient with L4-L5 or L5-S1 disc bulging and severe back spasms will not experience meaningful pain relief from oral corticosteroids—whether prednisone or methylprednisolone 1, 3, 2.

What Actually Works

For acute radiculopathy with severe spasms:

• NSAIDs provide small to moderate pain relief (8.39 points on 0-100 scale) 1
• Skeletal muscle relaxants relieve short-term acute pain but cause sedation 1
• Consider transforaminal epidural steroid injection if conservative management fails—it provides faster short-term relief than oral steroids, though outcomes converge by 12 weeks 5

Common Pitfall

Physicians often prescribe oral steroids for radiculopathy based on their anti-inflammatory properties and anecdotal experience. However, high-quality evidence consistently demonstrates lack of efficacy for pain 1, 3, 2. The modest functional improvements seen in one trial 2 do not justify routine use given the adverse effect profile and absence of pain relief—the outcome patients care about most.